These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23438929)

  • 1. Renin inhibition reverses renal disease in transgenic mice by shifting the balance between profibrotic and antifibrotic agents.
    Kavvadas P; Weis L; Abed AB; Feldman DL; Dussaule JC; Chatziantoniou C
    Hypertension; 2013 Apr; 61(4):901-7. PubMed ID: 23438929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin inhibition ameliorates renal damage through prominent suppression of both angiotensin I and II in human renin angiotensinogen transgenic mice with high salt loading.
    Yoshida S; Ishizawa K; Ayuzawa N; Ueda K; Takeuchi M; Kawarazaki W; Fujita T; Nagase M
    Clin Exp Nephrol; 2014 Aug; 18(4):593-9. PubMed ID: 24154707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aliskiren reduced renal fibrosis in mice with chronic ischemic kidney injury--beyond the direct renin inhibition.
    Sun CY; Cherng WJ; Jian HZ; Hsu HH; Wu IW; Hsu HJ; Wu MS
    Hypertens Res; 2012 Mar; 35(3):304-11. PubMed ID: 22089535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent antihypertensive effect of aliskiren is accompanied by reduced proteinuria and normalization of glomerular area in Ren-2 transgenic rats.
    Rakusan D; Kujal P; Kramer HJ; Husková Z; Vanourková Z; Vernerová Z; Mrázová I; Thumová M; Cervenka L; Vanecková I
    Am J Physiol Renal Physiol; 2010 Oct; 299(4):F758-66. PubMed ID: 20668096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin inhibition improves cardiac function and remodeling after myocardial infarction independent of blood pressure.
    Westermann D; Riad A; Lettau O; Roks A; Savvatis K; Becher PM; Escher F; Jan Danser AH; Schultheiss HP; Tschöpe C
    Hypertension; 2008 Dec; 52(6):1068-75. PubMed ID: 18955663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment combining aliskiren with paricalcitol is effective against progressive renal tubulointerstitial fibrosis via dual blockade of intrarenal renin.
    Chung S; Kim S; Kim M; Koh ES; Shin SJ; Park CW; Chang YS; Kim HS
    PLoS One; 2017; 12(7):e0181757. PubMed ID: 28753620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renoprotective effects of the direct renin inhibitor aliskiren on gentamicin-induced nephrotoxicity in rats.
    Bae EH; Kim IJ; Joo SY; Kim EY; Choi JS; Kim CS; Ma SK; Lee J; Kim SW
    J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):348-61. PubMed ID: 23420778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aliskiren ameliorates renal inflammation and fibrosis induced by unilateral ureteral obstruction in mice.
    Choi DE; Jeong JY; Lim BJ; Chang YK; Na KR; Shin YT; Lee KW
    J Urol; 2011 Aug; 186(2):694-701. PubMed ID: 21683401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AT1 antagonism and renin inhibition in mice: pivotal role of targeting angiotensin II in chronic kidney disease.
    Fraune C; Lange S; Krebs C; Hölzel A; Baucke J; Divac N; Schwedhelm E; Streichert T; Velden J; Garrelds IM; Danser AH; Frenay AR; van Goor H; Jankowski V; Stahl R; Nguyen G; Wenzel UO
    Am J Physiol Renal Physiol; 2012 Oct; 303(7):F1037-48. PubMed ID: 22791343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aliskiren attenuates chronic carbon tetrachloride-induced liver injury in mice.
    Lee KC; Chan CC; Yang YY; Hsieh YC; Huang YH; Lin HC
    Eur J Clin Invest; 2012 Dec; 42(12):1261-71. PubMed ID: 22998019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The direct renin inhibitor aliskiren localizes and persists in rat kidneys.
    Feldman DL; Jin L; Xuan H; Persohn E; Zhou W; Schuetz H; Park JK; Muller DN; Luft FC
    Am J Physiol Renal Physiol; 2013 Dec; 305(11):F1593-602. PubMed ID: 23926182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary n-3 polyunsaturated fatty acids and direct renin inhibition improve electrical remodeling in a model of high human renin hypertension.
    Fischer R; Dechend R; Qadri F; Markovic M; Feldt S; Herse F; Park JK; Gapelyuk A; Schwarz I; Zacharzowsky UB; Plehm R; Safak E; Heuser A; Schirdewan A; Luft FC; Schunck WH; Muller DN
    Hypertension; 2008 Feb; 51(2):540-6. PubMed ID: 18158339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the renoprotective actions of the renin inhibitor aliskiren in experimental renal disease.
    Feldman DL
    Hypertens Res; 2010 Apr; 33(4):279-87. PubMed ID: 20203685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Direct renin inhibitor aliskiren in the treatment of cardiovascular and renal diseases].
    Horký K
    Vnitr Lek; 2010 Feb; 56(2):120-6. PubMed ID: 20329582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Handle region peptide counteracts the beneficial effects of the Renin inhibitor aliskiren in spontaneously hypertensive rats.
    van Esch JH; van Veghel R; Garrelds IM; Leijten F; Bouhuizen AM; Danser AH
    Hypertension; 2011 Apr; 57(4):852-8. PubMed ID: 21321303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synergistic effect of mizoribine and a direct renin inhibitor, aliskiren, on unilateral ureteral obstruction induced renal fibrosis in rats.
    Sakuraya K; Endo A; Someya T; Hirano D; Murano Y; Fujinaga S; Ohtomo Y; Shimizu T
    J Urol; 2014 Apr; 191(4):1139-46. PubMed ID: 24140549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aliskiren enhances the protective effects of valsartan against cardiovascular and renal injury in endothelial nitric oxide synthase-deficient mice.
    Yamamoto E; Kataoka K; Dong YF; Nakamura T; Fukuda M; Tokutomi Y; Matsuba S; Nako H; Nakagata N; Kaneko T; Ogawa H; Kim-Mitsuyama S
    Hypertension; 2009 Sep; 54(3):633-8. PubMed ID: 19597038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney disease.
    Lizakowski S; Tylicki L; Renke M; Rutkowski P; Heleniak Z; Sławińska-Morawska M; Aleksandrowicz-Wrona E; Małgorzewicz S; Rutkowski B
    Am J Hypertens; 2012 Jun; 25(6):636-9. PubMed ID: 22357413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal protective effects of aliskiren beyond its antihypertensive property in a mouse model of progressive fibrosis.
    Gross O; Girgert R; Rubel D; Temme J; Theissen S; Müller GA
    Am J Hypertens; 2011 Mar; 24(3):355-61. PubMed ID: 21127470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.